One Stop Shop for All Your Market Research Reports

Global Biologics Safety Testing Market Size, Status and Forecast 2021-2027

Biologics are advanced drugs used in treatment of cancer, rheumatoid arthritis, and other diseases. These biologics constitutes large molecules such as monoclonal antibodies, recombinant proteins and their safety ensures patient safety as these are used in the treatment of different diseases. Market Analysis and Insights: Global Biologics Safety Testing Market The global Biologics Safety Testing market size is projected to reach US$ 3976.4 million by 2027, from US$ 2467.4 million in 2020, at a CAGR of 7.0% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologics Safety Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologics Safety Testing market in terms of revenue. On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologics Safety Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologics Safety Testing market. Global Biologics Safety Testing Scope and Market Size Biologics Safety Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biologics Safety Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type Endotoxin Tests Sterility Tests Cell Line Authentication and Characterization Tests Bioburden Tests Cell Line Authentication Residual Host Contaminant Detection Tests Adventitious Agent Detection Tests Others Segment by Application Pharmaceutical Medical Research By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Nordic Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA By Company Lonza Group Charles River Merck SGS WuXi AppTec Thermo Fisher Scientific Sartorius Cytovance Biologics Pace Analytical Services Toxikon
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Biologics Safety Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Endotoxin Tests 1.2.3 Sterility Tests 1.2.4 Cell Line Authentication and Characterization Tests 1.2.5 Bioburden Tests 1.2.6 Cell Line Authentication 1.2.7 Residual Host Contami
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3900
Multi User US $5850
Corporate User US $7800
About this Report
Report ID 392904
Category
  • Healthcare
Published on 30-Dec-21
Number of Pages 106
Publisher Name QY Research
Editor Rating
★★★★★
★★★★★
(39)